vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and SuperCom Ltd (SPCB). Click either name above to swap in a different company.
SuperCom Ltd is the larger business by last-quarter revenue ($14.2M vs $13.8M, roughly 1.0× Gossamer Bio, Inc.). SuperCom Ltd runs the higher net margin — 37.5% vs -342.3%, a 379.8% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -1.5%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Super.com is a technology company headquartered in San Francisco and co-founded by Hussein Fazal and Henry Shi. The company provides financial services, including reward programs and travel bookings.
GOSS vs SPCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $14.2M |
| Net Profit | $-47.2M | $5.3M |
| Gross Margin | — | 61.2% |
| Operating Margin | -333.6% | 16.3% |
| Net Margin | -342.3% | 37.5% |
| Revenue YoY | 47.1% | -1.5% |
| Net Profit YoY | -43.0% | 79.5% |
| EPS (diluted) | $-0.21 | $1.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.3M | — | ||
| Q2 25 | — | $14.2M | ||
| Q2 24 | $95.8M | $14.4M | ||
| Q1 24 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | $14.1M | ||
| Q2 22 | — | $6.3M |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | — | ||
| Q2 25 | — | $5.3M | ||
| Q2 24 | $49.2M | $3.0M | ||
| Q1 24 | $-41.9M | — | ||
| Q3 23 | $-40.0M | — | ||
| Q2 23 | $-42.5M | $-2.6M | ||
| Q2 22 | — | $-5.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 61.2% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 27.2% | ||
| Q2 22 | — | 41.8% |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | — | ||
| Q2 25 | — | 16.3% | ||
| Q2 24 | 54.3% | 7.7% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -12.2% | ||
| Q2 22 | — | -49.9% |
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | — | ||
| Q2 25 | — | 37.5% | ||
| Q2 24 | 51.4% | 20.6% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -18.3% | ||
| Q2 22 | — | -82.4% |
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | — | ||
| Q2 25 | — | $1.32 | ||
| Q2 24 | $0.22 | $1.19 | ||
| Q1 24 | $-0.19 | — | ||
| Q3 23 | $-0.21 | — | ||
| Q2 23 | $-0.45 | $-10.66 | ||
| Q2 22 | — | $-1.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $15.0M |
| Total DebtLower is stronger | — | $23.6M |
| Stockholders' EquityBook value | $-122.8M | $37.3M |
| Total Assets | $172.2M | $65.5M |
| Debt / EquityLower = less leverage | — | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | — | ||
| Q2 25 | — | $15.0M | ||
| Q2 24 | $354.5M | $5.7M | ||
| Q1 24 | $244.4M | — | ||
| Q3 23 | $328.9M | — | ||
| Q2 23 | $162.1M | $1.1M | ||
| Q2 22 | — | $2.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $23.6M | ||
| Q2 24 | — | $29.2M | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $32.9M | ||
| Q2 22 | — | $32.3M |
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | — | ||
| Q2 25 | — | $37.3M | ||
| Q2 24 | $81.5M | $13.8M | ||
| Q1 24 | $26.7M | — | ||
| Q3 23 | $104.6M | — | ||
| Q2 23 | $-62.8M | $3.5M | ||
| Q2 22 | — | $3.7M |
| Q4 25 | $172.2M | — | ||
| Q3 25 | $208.8M | — | ||
| Q2 25 | — | $65.5M | ||
| Q2 24 | $373.4M | $49.6M | ||
| Q1 24 | $259.4M | — | ||
| Q3 23 | $347.9M | — | ||
| Q2 23 | $181.7M | $40.8M | ||
| Q2 22 | — | $42.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.63× | ||
| Q2 24 | — | 2.11× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 9.49× | ||
| Q2 22 | — | 8.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $-2.2M |
| Free Cash FlowOCF − Capex | — | $-3.6M |
| FCF MarginFCF / Revenue | — | -25.3% |
| Capex IntensityCapex / Revenue | 0.0% | 10.0% |
| Cash ConversionOCF / Net Profit | — | -0.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-14.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | — | ||
| Q3 25 | $-36.2M | — | ||
| Q2 25 | — | $-2.2M | ||
| Q2 24 | $116.3M | $-950.0K | ||
| Q1 24 | $-52.3M | — | ||
| Q3 23 | $-34.5M | — | ||
| Q2 23 | $-38.3M | $-3.4M | ||
| Q2 22 | — | $-4.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-3.6M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $-4.5M | ||
| Q2 22 | — | $-4.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -25.3% | ||
| Q2 24 | — | -10.8% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -31.5% | ||
| Q2 22 | — | -70.4% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | 10.0% | ||
| Q2 24 | 0.0% | 4.2% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 7.4% | ||
| Q2 22 | — | 4.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.41× | ||
| Q2 24 | 2.36× | -0.32× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
